Reports - Gene Editing Market
HealthcareGene Editing Market
Gene Editing Market Size and Share Analysis for 2035 by Product & Service (Reagents & Consumables, Software & Systems, Services) by Technology (CRISPER, TALEN, ZFN, ANTISENE, Other Technologies) by Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Other Applications) by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Gene Editing Market - Segment Analysis
1. Overview
2. Global Gene Editing Market, 2021 - 2035 (USD Million)
3. Global Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. Global Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. Global Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. Global Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
7. Global Gene Editing Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Gene Editing Market - Segment Analysis
1. Overview
2. North America Gene Editing Market, 2021 - 2035 (USD Million)
3. North America Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. North America Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. North America Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. North America Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
Chapter 5 Europe Gene Editing Market - Segment Analysis
1. Overview
2. Europe Gene Editing Market, 2021 - 2035 (USD Million)
3. Europe Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. Europe Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. Europe Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. Europe Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
Chapter 6 Asia Pacific Gene Editing Market - Segment Analysis
1. Overview
2. Asia Pacific Gene Editing Market, 2021 - 2035 (USD Million)
3. Asia Pacific Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. Asia Pacific Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. Asia Pacific Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. Asia Pacific Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
Chapter 7 Latin America Gene Editing Market - Segment Analysis
1. Overview
2. Latin America Gene Editing Market, 2021 - 2035 (USD Million)
3. Latin America Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. Latin America Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. Latin America Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. Latin America Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
Chapter 8 Middle East & Africa Gene Editing Market - Segment Analysis
1. Overview
2. Middle East & Africa Gene Editing Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Gene Editing Market - by Product & Service
3.1. By Reagents & Consumables
3.2. By Software & Systems
3.3. By Services
4. Middle East & Africa Gene Editing Market - by Technology
4.1. By CRISPER
4.2. By TALEN
4.3. By ZFN
4.4. By ANTISENE
4.5. By Other Technologies
5. Middle East & Africa Gene Editing Market - by Application
5.1. By Cell Line Engineering
5.2. By Genetic Engineering
5.3. By Drug Discovery & Development
5.4. By Other Applications
6. Middle East & Africa Gene Editing Market - by End User
6.1. By Pharmaceutical & Biotechnology Companies
6.2. By Academic & Research Institutes
6.3. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Lonza Group Ltd. (Switzerland)
2. Perkinelmer Inc. (U.S.)
3. CRISPR Therapeutics AG (Switzerland)
4. Thermo Fisher Scientific Inc. (U.S.)
5. Eurofins Scientific (Luxembourg)
6. Aglient Technologies Inc. (U.S.)
7. Danaher Corporation (U.S.)
8. Genscript Biotech Corporation (U.S.)
9. Merck KGAA (Germany)
10. Editas Medicine Inc. (U.S.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By